208 related articles for article (PubMed ID: 22989997)
1. Expression of complement receptors 1 (CR1/CD35) and 2 (CR2/CD21), and co-signaling molecule CD19 in cattle.
Pringle ES; Firth MA; Chattha KS; Hodgins DC; Shewen PE
Dev Comp Immunol; 2012 Dec; 38(4):487-94. PubMed ID: 22989997
[TBL] [Abstract][Full Text] [Related]
2. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
3. Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1.
Donius LR; Orlando CM; Weis JJ; Weis JH
Immunobiology; 2014 Jan; 219(1):53-63. PubMed ID: 24012440
[TBL] [Abstract][Full Text] [Related]
4. Detection of complement receptors 1 and 2 on mouse splenic B cells using flow cytometry.
Donius LR; Weis JH
Methods Mol Biol; 2014; 1100():305-10. PubMed ID: 24218269
[TBL] [Abstract][Full Text] [Related]
5. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.
Kremlitzka M; Polgár A; Fülöp L; Kiss E; Poór G; Erdei A
Int Immunol; 2013 Jan; 25(1):25-33. PubMed ID: 22962438
[TBL] [Abstract][Full Text] [Related]
6. Murine macrophages lack expression of the Cr2-145 (CR2) and Cr2-190 (CR1) gene products.
Martin BK; Weis JH
Eur J Immunol; 1993 Nov; 23(11):3037-42. PubMed ID: 7693486
[TBL] [Abstract][Full Text] [Related]
7. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation.
Gommerman JL; Oh DY; Zhou X; Tedder TF; Maurer M; Galli SJ; Carroll MC
J Immunol; 2000 Dec; 165(12):6915-21. PubMed ID: 11120817
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of complement C3 receptors on human astrocytes.
Gasque P; Chan P; Mauger C; Schouft MT; Singhrao S; Dierich MP; Morgan BP; Fontaine M
J Immunol; 1996 Mar; 156(6):2247-55. PubMed ID: 8690915
[TBL] [Abstract][Full Text] [Related]
9. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
Kazatchkine MD; Fearon DT
Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
[TBL] [Abstract][Full Text] [Related]
10. CD21/CD35 in B cell activation.
Carroll MC
Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
[TBL] [Abstract][Full Text] [Related]
11. Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes.
Leslie RG; Prodinger WM; Nielsen CH
Eur J Immunol; 2003 Dec; 33(12):3311-21. PubMed ID: 14635039
[TBL] [Abstract][Full Text] [Related]
12. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM
Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881
[TBL] [Abstract][Full Text] [Related]
13. The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells.
Nielsen CH; Pedersen ML; Marquart HV; Prodinger WM; Leslie RG
Eur J Immunol; 2002 May; 32(5):1359-67. PubMed ID: 11981823
[TBL] [Abstract][Full Text] [Related]
14. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
Delibrias CC; Fischer E; Bismuth G; Kazatchkine MD
J Immunol; 1992 Aug; 149(3):768-74. PubMed ID: 1386093
[TBL] [Abstract][Full Text] [Related]
15. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus.
Delibrias CC; Mouhoub A; Fischer E; Kazatchkine MD
Eur J Immunol; 1994 Nov; 24(11):2784-8. PubMed ID: 7957570
[TBL] [Abstract][Full Text] [Related]
16. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
17. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients.
Isaák A; Gergely P; Szekeres Z; Prechl J; Poór G; Erdei A; Gergely J
Int Immunol; 2008 Feb; 20(2):185-92. PubMed ID: 18182380
[TBL] [Abstract][Full Text] [Related]
18. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling CD21 and CD19 of the B-cell coreceptor.
Barrington RA; Schneider TJ; Pitcher LA; Mempel TR; Ma M; Barteneva NS; Carroll MC
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14490-5. PubMed ID: 19706534
[TBL] [Abstract][Full Text] [Related]
20. Novel roles for murine complement receptors type 1 and 2 I. Regulation of B cell survival and proliferation by CR1/2.
Molnár E; Erdei A; Prechl J
Immunol Lett; 2008 Mar; 116(2):156-62. PubMed ID: 18243341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
